## Abstract SARSβCoV is a new type of human coronavirus identified as a causative agent of severe acute respiratory syndrome (SARS). On the occasion of the SARS outbreak, various monoclonal antibodies (mAbs) against SARSβCoV have been developed and applied for diagnosis, clinical management and bas
β¦ LIBER β¦
Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus
β Scribed by Cavanagh, Dave
- Book ID
- 120879252
- Publisher
- Taylor and Francis Group
- Year
- 2003
- Tongue
- English
- Weight
- 264 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0307-9457
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Severe acute respiratory syndrome (SARS)
β
Yasuko Tsunetsugu-Yokota; Kazuo Ohnishi; Toshitada Takemori
π
Article
π
2006
π
John Wiley and Sons
π
English
β 303 KB
Roadmap to developing a recombinant coro
β
Jiang, Shibo; Bottazzi, MariaΒ Elena; Du, Lanying; Lustigman, Sara; Tseng, Chien-
π
Article
π
2012
π
Expert Reviews
π
English
β 981 KB
Synthetic Peptide Studies on the Severe
β
Wai-Yan Choy, Shu-Guang Lin, Paul Kay-Sheung Chan, John Siu-Lun Tam, Y.M. Dennis
π
Article
π
2004
π
American Association for Clinical Chemistry
π
English
β 451 KB
---------------------Note: This study is meant for inspiration for scientific circles around the world with respect to scientific inquiry. The hypothesis, results, data and so forth of this study shall not be subjected to any interpretation, truncation or obfuscation in order to serve the purposes o
Preparation and development of equine hy
β
Jai-hai LU; Zhong-min GUO; Wen-yu HAN; Guo-ling WANG; Ding-mei ZHANG; Yi-fei WAN
π
Article
π
2005
π
Nature Publishing Group
π
Chinese
β 780 KB
Coronavirus replication and pathogenesis
β
Sonia Navas-MartΓn; Susan R. Weiss
π
Article
π
2004
π
Springer US
π
English
β 139 KB
Severe acute respiratory syndrome (SARS)
β
Pogrebnyak, N.
π
Article
π
2005
π
National Academy of Sciences
π
English
β 505 KB